These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38809250)

  • 1. Impact of Risk Stratification in Patients With Diabetes Mellitus in a Health System Specialty Pharmacy Setting.
    Stout M; Giavatto C; McDonald N; Bryant L; Ross C; Fitzpatrick C; Mourani J; Lopez-Medina AI
    J Pharm Pract; 2024 Dec; 37(6):1325-1330. PubMed ID: 38809250
    [No Abstract]   [Full Text] [Related]  

  • 2. Health-system specialty pharmacy role and outcomes: A review of current literature.
    Zuckerman AD; Whelchel K; Kozlicki M; Simonyan AR; Donovan JL; Gazda NP; Mourani J; Smith AM; Young L; Ortega M; Kelley TN
    Am J Health Syst Pharm; 2022 Oct; 79(21):1906-1918. PubMed ID: 35916907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a clinical pharmacy program on changes in hemoglobin A1c, diabetes-related hospitalizations, and diabetes-related emergency department visits for patients with diabetes in an underserved population.
    Chung N; Rascati K; Lopez D; Jokerst J; Garza A
    J Manag Care Spec Pharm; 2014 Sep; 20(9):914-9. PubMed ID: 25166290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a Pharmacist-Managed Diabetes Program in a Primary Care Setting Within an Integrated Health Care System.
    Benedict AW; Spence MM; Sie JL; Chin HA; Ngo CD; Salmingo JF; Vidaurreta AT; Rashid N
    J Manag Care Spec Pharm; 2018 Feb; 24(2):114-122. PubMed ID: 29384029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Provision of ambrisentan from a health-system specialty pharmacy affiliated with a pulmonary hypertension Center of Comprehensive Care.
    Gutenschwager DW; Patel A; Soyad AT; Patel S; Szandzik EG; Kelly B; Smith ZR
    Am J Health Syst Pharm; 2024 Jan; 81(2):66-73. PubMed ID: 37611180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pharmacy services on time to elexacaftor-tezacaftor-ivacaftor initiation.
    Roder L; Simonsen M; Fitzpatrick L; He J; Loucks J
    J Manag Care Spec Pharm; 2022 Sep; 28(9):989-996. PubMed ID: 36001103
    [No Abstract]   [Full Text] [Related]  

  • 7. Adherence to oral oncolytics filled through an internal health-system specialty pharmacy compared with external specialty pharmacies.
    Academia EC; Mejías-De Jesús CM; Stevens JS; Jia LY; Yankama T; Patel C; Lee J
    J Manag Care Spec Pharm; 2021 Oct; 27(10):1438-1446. PubMed ID: 34595953
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of home telehealth monitoring with active medication therapy management by clinical pharmacists in veterans with poorly controlled type 2 diabetes mellitus.
    McFarland M; Davis K; Wallace J; Wan J; Cassidy R; Morgan T; Venugopal D
    Pharmacotherapy; 2012 May; 32(5):420-6. PubMed ID: 22488512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the impact of a health-system specialty pharmacy patient management program on achieving predefined clinical outcome measures.
    O'Reilly E; Foushee S; Nolan L; Maier C; McPheeters C
    Am J Health Syst Pharm; 2024 Apr; 81(9):e226-e233. PubMed ID: 38169475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Impact of a Pharmacist-Led Telehealth Clinic on Diabetes-Related Goals of Therapy in a Veteran Population.
    Maxwell LG; McFarland MS; Baker JW; Cassidy RF
    Pharmacotherapy; 2016 Mar; 36(3):348-56. PubMed ID: 26877253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2022 ASHP Survey of Health-System Specialty Pharmacy Practice: Clinical Services.
    Zuckerman AD; Mourani J; Smith A; Ortega M; Donovan JL; Gazda NP; Tong K; Simonson D; Kelley T; DeClercq J; Choi L; Pierce G
    Am J Health Syst Pharm; 2023 Jun; 80(13):827-841. PubMed ID: 36999452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of time to treatment initiation of specialty medications between an integrated health system specialty pharmacy and external specialty pharmacies.
    Russell M; McCoy H; Platt T; Zeltner M; Rhudy C
    J Manag Care Spec Pharm; 2024 Apr; 30(4):352-362. PubMed ID: 38555622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Glycemic Control of a Pharmacist-Led Medication Management Program in Patients with Type 2 Diabetes.
    Ko JJ; Lu J; Rascati K; Stock EM; Juan J; Suh K; Kim Y; Tabor PA; Godley PJ
    J Manag Care Spec Pharm; 2016 Jan; 22(1):32-7. PubMed ID: 27015049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated Cost-Effectiveness, Cost Benefit, and Risk Reduction Associated with an Endocrinologist-Pharmacist Diabetes Intense Medical Management "Tune-Up" Clinic.
    Hirsch JD; Bounthavong M; Arjmand A; Ha DR; Cadiz CL; Zimmerman A; Ourth H; Morreale AP; Edelman SV; Morello CM
    J Manag Care Spec Pharm; 2017 Mar; 23(3):318-326. PubMed ID: 28230459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a clinical pharmacist team-based telehealth intervention in a rural clinic setting: a pilot study of feasibility, organizational perceptions, and return on investment.
    Murry LT; Parker CP; Finkelstein RJ; Arnold M; Kennelty K
    Pilot Feasibility Stud; 2020; 6():127. PubMed ID: 32944275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A1C Reduction in Patients Who Declined Pharmacist-Led Diabetes Management Services.
    Ahmed F; Hammad SA; Lin JF; Gennaro TL; Gaspard AL; Sarpong DF; Onor IO
    J Pharm Pract; 2022 Jun; 35(3):413-421. PubMed ID: 33567944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a Pharmacist-Managed Antidiabetic Deprescribing Program in an Integrated Health Care System.
    Hui RL; Chang CC; Niu F; Tang YK; Harano D; Deguzman L; Kao DJ; Awsare S; Draves M
    J Manag Care Spec Pharm; 2019 Aug; 25(8):927-934. PubMed ID: 31347983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Droxidopa management by an integrated health-system specialty pharmacy team.
    Livezey SN; Shah NB; DeClercq J; Keefe J; Choi L; Shibao C; Zuckerman AD
    J Am Pharm Assoc (2003); 2022; 62(6):1904-1911. PubMed ID: 35787811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Pharmacist-Driven Professional Continuous Glucose Monitoring in Adults with Uncontrolled Diabetes.
    Sherrill CH; Houpt CT; Dixon EM; Richter SJ
    J Manag Care Spec Pharm; 2020 May; 26(5):600-609. PubMed ID: 32347180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Federal Bureau of Prisons clinical pharmacy program improves patient A1C.
    Bingham JT; Mallette JJ
    J Am Pharm Assoc (2003); 2016; 56(2):173-7. PubMed ID: 27000168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.